Trade-Ideas: Globus Medical (GMED) Is Today's

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Globus Medical ( GMED) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Globus Medical as such a stock due to the following factors:

  • GMED has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $22.1 million.
  • GMED has traded 60,840 shares today.
  • GMED is up 3.4% today.
  • GMED was down 18% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in GMED with the Ticky from Trade-Ideas. See the FREE profile for GMED NOW at Trade-Ideas

More details on GMED:

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. GMED has a PE ratio of 29.7. Currently there are 5 analysts that rate Globus Medical a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for Globus Medical has been 477,000 shares per day over the past 30 days. Globus Medical has a market cap of $1.5 billion and is part of the health care sector and health services industry. The stock has a beta of 2122.19 and a short float of 4.4% with 3.24 days to cover. Shares are down 8.3% year-to-date as of the close of trading on Wednesday.

If you liked this article you might like

Analysts' Actions -- F5 Networks, GoPro, Lockheed Martin, U.S. Steel and More

Trade-Ideas: Globus Medical (GMED) Is Today's "Dead Cat Bounce" Stock

Analysts' Actions -- Alaska Air, Southwest, Coach, Twitter and More

These 5 Stocks Are Breaking Out This Summer

2 Fundamentally Strong Medical Device Stocks to Buy Now